Additional file 3 of Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Osman Öcal (Creatore)
Regina Schinner (Creatore)
Kerstin Schütte (Creatore)
Enrico N. De Toni (Creatore)
Christian Loewe (Creatore)
Otto van Delden (Creatore)
Vincent Vandecaveye (Creatore)
Bernhard Gebauer (Creatore)
Christoph J Zech (Creatore)
Christian Sengel (Creatore)
Irene Bargellini (Creatore)
Antonio Gasbarrini (Creatore)
Bruno Sangro (Creatore)
Maciej Pech (Creatore)
Peter Malfertheiner (Creatore)
Jens Ricke (Creatore)
Max Seidensticker (Creatore)

Dataset

Description

Additional file 3: Supplementary Fig. 3. Overall survival of patients with partial response according to depth of response (DpR) more or less than the median DpR. CI, confidence interval; HR, hazard ratio.

Dati resi disponibili	2022
Editore	figshare

DOI
10.6084/m9.figshare.17870628

Accesso dataset

Creative Commons Attribution 4.0 International

Cita questo

DataSetCite

Öcal, O. (Creatore), Schinner, R. (Creatore), Schütte, K. (Creatore), de Toni, E. N. (Creatore), Loewe, C. (Creatore), van Delden, O. (Creatore), Vandecaveye, V. (Creatore), Gebauer, B. (Creatore), Zech, C. J. (Creatore), Sengel, C. (Creatore), Bargellini, I. (Creatore), Gasbarrini, A. (Creatore), Sangro, B. (Creatore), Pech, M. (Creatore), Malfertheiner, P. (Creatore), Ricke, J. (Creatore), Seidensticker, M. (Creatore) (2022). Additional file 3 of Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib. figshare. 10.6084/m9.figshare.17870628

Additional file 3 of Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Description

DOI

Accesso dataset

Cita questo